The Lustgarten Foundation is the largest private funder of the world’s preeminent pancreatic cancer researchers.
To date, we have funded more than $225 million in research grants and been a leading force in every major advancement in pancreatic cancer research.
Progress is paramount. We drive bold, innovative research with the singular mission: transforming pancreatic cancer into a curable disease.
In this installment of LustgartenLIVE! doctors Avery Posey, Edwin Manuel and Howard Crawford discuss the importance of equity, accessibility and diversity in pancreatic cancer research. Join us June 15 as we lead the way to new milestones in pancreatic cancer research.
Lustgarten and the Salk Institute announced a new strategic partnership supported by a $5 million grant and focused on identifying and validating potential targets for new pancreatic cancer drugs.
Solving the unique complexities of pancreatic cancer requires complex thinking and diversity of thought, education,training, background and experience. We are committed to prioritizing and promoting diversity and inclusion acrossthe organization, including staff, volunteer leadership and research portfolio. ResearchA rich field of experience and perspectives working on the complex problems associated with pancreatic cancer increases the […]
News From Lustgarten
Picking the Winners: Study Sheds Light on Possible Best Targets for Pancreatic Cancer Vaccine
Northwestern Medicine investigators have discovered a potential therapeutic target for the most common type of pancreatic cancer, according to a study published in Developmental Cell.
Cancer death rates among Black people declined over time, but remain higher than other racial and ethnic groups
From Nurse to Patient
When Susan was diagnosed with pancreatic cancer, cutting-edge drugs and a supportive medical team helped her go from patient to survivor. Now she raises funds for continued research through a Lustgarten Foundation Walk for Research.Read Susan’s Story